182499-89-4

Basic information

• Product Name: 2-AMINO-4-BROMO-6-FLUOROPHENOL
• Synonyms: 2-AMINO-4-BROMO-6-FLUOROPHENOL;5-Bromo-3-fluoro-2-hydroxyaniline;2-Amino-4-bromo-6-fluorophenol 97%;2-Amino-4-bromo-6-fluorophenol97%
• CAS NO: 182499-89-4
• Molecular Formula: C₆H₅BrFNO
• Molecular Weight: 206.01
• Product Categories: Fluorine series
• Mol File: 182499-89-4.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 260.2±40.0 °C(Predicted)
• Appearance: /
• Density: 1.863±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 7.94±0.23(Predicted)
• CAS DataBase Reference: 2-AMINO-4-BROMO-6-FLUOROPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-4-BROMO-6-FLUOROPHENOL(182499-89-4)
• EPA Substance Registry System: 2-AMINO-4-BROMO-6-FLUOROPHENOL(182499-89-4)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 182499-89-4(Hazardous Substances Data)

Usage

General Description

2-AMINO-4-BROMO-6-FLUOROPHENOL is a chemical compound with the molecular formula C6H5BrFNO. It is a phenolic compound that contains an amino group, a bromine atom, and a fluorine atom attached to a benzene ring. 2-AMINO-4-BROMO-6-FLUOROPHENOL is used in various chemical reactions and pharmaceutical applications, including the synthesis of pharmaceutical drugs and agrochemicals. It may also be used as an intermediate for the production of other organic compounds. 2-AMINO-4-BROMO-6-FLUOROPHENOL is known for its potential as a building block in organic synthesis and its important role in the development of new molecules with desired properties.

Upstream product

• 320-76-3 2-fluoro-4-bromo-6-nitro-phenol 
• 140-89-6 potassium ethyl xanthogenate 
• 7772-99-8 stannous chloride 

Downstream Products

• 1256255-94-3 6-bromo-8-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine 
• 1415992-39-0 7-fluoro-2-[2-fluoro-4-(methylsulfonyl)phenyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole 
• 1415992-38-9 5-bromo-7-fluoro-2-[2-fluoro-4-(methylsulfonyl)phenyl]benzo[d]oxazole 
• 560082-53-3 6-bromo-8-fluoro-3,4-dihydro-2H-1,4-benzoxazin-3-one 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

AMINO PYRIMIDINE COMPOUND FOR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY

An amino pyrimidine compound for inhibiting protein tyrosine kinase activity, a pharmaceutical composition thereof, preparation therefor, and an application thereof. Specifically, an amino pyrimidine compound represented by formula (I), R1, R2, L, Y, R6, W, A, m, and n being defined in the specification, and a pharmaceutically acceptable salt, a stereoisomer, a solvent compound, a hydrate, a polymorphism, a prodrug, or an isotope variant thereof. The compound can be used for treating and/or preventing protein tyrosine kinase-related diseases such as cell proliferative diseases, cancers, and immune diseases.

ANTAGONIST DERIVATIVES OF THE VITRONECTIN RECEPTOR

The invention concerns vitronectin receptor antagonist compounds of formula (I): R1—Y-A-B-D-E-F-G wherein R1, Y, A, B, D, E, F, and G are as defined in the description, their physiologically acceptable salts and their prodrugs, metho